Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis

Neuroscience Letters

Volumn 620, Issue , 2016, Pages 1-7

  Yao, Gang ^a,b   Wang, Ping ^c   Luo, Xiang Dan ^a   Yu, Ting Min ^a   Harris, Robert A ^b   Zhang, Xing Mei ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Helicobacter pylori; Meta analysis; Multiple sclerosis

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HUMAN; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; PUBLISHING; QUALITY CONTROL; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; CASE CONTROL STUDY; COMPLICATION; DISEASE PREDISPOSITION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; META ANALYSIS; MICROBIOLOGY; PHYSIOLOGY;

CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MULTIPLE SCLEROSIS;

EID: 84961625755     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.03.037     Document Type: Article

References (45)

1. Bodger K., et al. Helicobacter pylori and gastric inflammation. Br. Med. Bull. 1998, 54(1):139-150.
2. Porras C., et al. Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG trial S0701). Cancer Causes Control 2013, 24(2):209-215.
3. Kusters J.G., et al. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev. 2006, 19(3):449-490.
4. Banatvala N., et al. The cohort effect and Helicobacter pylori. J. Infect. Dis. 1993, 168(1):219-221.
5. Kountouras J., et al. Association between cirrhosis and Helicobacter pylori-related brain pathologies. Eur. J. Gastroenterol. Hepatol. 2015, 27(2):183.
6. Bulajic M., et al. Helicobacter pylori and pancreatic diseases. World J. Gastrointest. Pathophysiol. 2014, 5(4):380-383.
7. Huang W.S., et al. Helicobacter pylori infection increases subsequent ischemic stroke risk: a nationwide population-based retrospective cohort study. QJM 2014, 107(12):969-975.
8. Faraji F., et al. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. Pain Physician 2012, 15(6):495-498.
9. Kountouras J., et al. A potential impact of chronic Helicobacter pylori infection on Alzheimer's disease pathobiology and course. Neurobiol. Aging 2012, 33(7):e3-4.
10. Smyk D.S., et al. Helicobacter pylori and autoimmune disease: cause or bystander. World J. Gastroenterol. 2014, 20(3):613-629.
11. Xiao M., et al. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One 2013, 8(9):e75559.
12. Khan F., et al. Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. J. Pain 2007, 8(8):614-623.
13. Solaro C., et al. Management of pain in multiple sclerosis: a pharmacological approach. Nat. Rev. Neurol. 2011, 7(9):519-527.
14. Ebers G.C. Environmental factors and multiple sclerosis. Lancet Neurol. 2008, 7(3):268-277.
15. Yoshimura S., et al. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One 2014, 9(4):e95367.
16. Bennett K.A., et al. Western Australian multiple sclerosis patients exhibit a lower prevalence of helicobacter pylori infection. Mult. Scler. 2012, 18(4):521.
17. Bennett K.A., et al. Western Australian multiple sclerosis patients exhibit a lower prevalence of Helicobacter pylori infection. Mult. Scler. 2012, 18(5):700.
18. Cook K.W., et al. Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front. Microbiol. 2015, 6:52.
19. Gavalas E., et al. Helicobacter pylori and multiple sclerosis. J. Neuroimmunol. 2007, 188(1):187-189.
20. Isobe N. Environmental factors in Japan. Mult. Scler. 2010, 16(2):260.
21. Malli C., et al. Environmental factors related to multiple sclerosis in Indian population. PLoS One 2015, 10(4):e0124064.
22. Mohebi N., et al. Relation of Helicobacter pylori infection and multiple sclerosis in Iranian patients. Neurol. Int. 2013, 5(2):31-33.
23. Pedrini M.J., et al. Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females. J. Neurol. Neurosurg. Psychiatry 2015, 86(6):603-607.
24. Pedrini M.J., et al. Helicobacter pylori infection as a protective factor against multiple sclerosis risk in Western Australian females. Mult. Scler. 2013, 19(11):157.
25. Wender M. Prevalence of Helicobacter pylori infection among patients with multiple sclerosis. Neurol. Neurochir. Pol. 2003, 37(1):45-48.
26. Yoshimura S., et al. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One 2012, 7(11):e48592.
27. Cossu D., et al. Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?. Mult. Scler. 2012, 18(8):1181-1184.
28. Li W., et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J. Neuroimmunol. 2007, 184(1-2):227-231.
29. Li W., et al. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult. Scler. 2009, 15(12):1411-1421.
30. Long Y., et al. Helicobacter pylori infection in neuromyelitis optica and multiple sclerosis. Neuroimmunomodulation 2013, 20(2):107-112.
31. Pedrini M.J., et al. Helicobacter pylori infection as a protective factor against multiple sclerosis risk in Western Australian females. Mult. Scler. 2014, 20(7):910.
32. Ramroodi N., et al. Relationship between Helicobacter pylori infection and multiple sclerosis (MS) in South-east Iran. Afr. J. Microbiol. Res. 2012, 6(23):5015-5019.
33. Riskind P.N., et al. Prevalence of Helicobacter pylori seropositivity (HP+) in American patients with multiple sclerosis. Mult. Scler. 2010, 16(8):1008.
34. Yoshimura S., et al. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J. Neurol. Neurosurg. Psychiatry 2013, 84(1):29-34.
35. Zarkesh H., et al. The relationship between multiple sclerosis and Helicobacter pylori infection. Mult. Scler. 2009, 15(9):S87.
36. Gavalas E., et al. Relationship between Helicobacter pylori infection and multiple sclerosis. Ann Gastroenterol. 2015, 28(3):353-356.
37. Deretzi G., et al. Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome. Acta Neurol. Scand. 2015, [Epubaheadofprint]. 10.1111/ane.12453.
38. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25(9):603-605.
39. Xiao M., et al. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One 2013, 8(9):e75559.
40. Su J., et al. Association between Helicobacter pylori infection and migraine: a meta-analysis. World J. Gastroenterol. 2014, 20(40):14965-14972.
41. Cremonini F., et al. Atopy, Helicobacter pylori and the hygiene hypothesis. Eur. J. Gastroenterol. Hepatol. 2003, 15(6):635-6366.
42. Robinson K. Helicobacter pylori-mediated protection against extra-gastric immune and inflammatory disorders: the evidence and controversies. Diseases 2015, 3(2):34-55.
43. Epplein M., et al. Neighborhood socio-economic characteristics, African ancestry, and Helicobacter pylori sero-prevalence. Cancer Causes Control 2012, 23(6):897-906.
44. Feng H., et al. Association between cirrhosis and Helicobacter pylori infection: a meta-analysis. Eur. J. Gastroenterol. Hepatol. 2014, 26(12):1309-1319.
45. Chey W.D., et al. Noninvasive Helicobacter pylori testing for the test-and-treat strategy: a decision analysis to assess the effect of past infection on test choice. Arch. Intern. Med. 2001, 161(17):2129-2132.